跳至主要内容
临床试验/IRCT20160706028815N4
IRCT20160706028815N4招募中2 期

Assessment of the effectiveness of addition of Crocin to doxorubicin containing chemotherapy regimen on survival of breast cancer patients

Mashhad University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
Female

入选标准

  • Newly diagnosed invasive breast cancer
  • The Karnofsky Performance Scale Index equal to or more than 70%
  • doxorubicin containing chemotherapy regimen
  • Unilateral breast cancer
  • Age between 18 to 70 years old

排除标准

  • chronic liver failure
  • chronic kidney failure
  • chronic heart failure
  • previous history of hematologic malignancies
  • History of taking Psychiatric drugs
  • Warfarin usage
  • Bipolar mood disorder
  • Evidence of metastasis

研究者

相似试验

Effect of Crocin in treatment of breast cancer | 临床试验